TargetMol

Ramixotidine

Product Code:
 
TAR-T26039
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T26039-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26039-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T26039-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Ramixotidine is a competitive antagonist of histamine H2-receptor.
CAS:
84071-15-8
Formula:
C16H21N3O3S
Molecular Weight:
335.42
Purity:
0.98
SMILES:
CN(C)Cc1ccc(CSCCNC(=O)c2cccn(=O)c2)o1

References

1. Molgora M, Basilisco G, Bozzani A, Camboni G, Bianchi PA. Intragastric and intraoesophageal pH monitoring in duodenal ulcerpatients: effect of the new histamine H2-receptor antagonist ramixotidine. Eur J Clin Pharmacol. 1989;37(4):405-7. PubMed PMID: 2574675. 2. Brassinne A, Dresse A, Basilisco G, Manara L. Inhibition of pentagastrin-stimulated gastric acid secretion and plasma levels of the new histamine H2-receptor antagonist ramixotidine dihydrochloride (CM 57755) in human volunteers. Eur J Clin Pharmacol. 1987;32(5):467-70. PubMed PMID: 2957210. 3. Soldani G, Lavezzo A, Bianchetti A, Manzoni L, Mengozzi G, Manara L. Comparison of the gastric antisecretory effects of ramixotidine dihydrochloride (CM 57755), a new H2 receptor antagonist, and cimetidine in dogs. Pharmacol Res Commun. 1988 Aug;20(8):663-72. PubMed PMID: 2974998. 4. Colle M, Ruedas E, Cazenave J, Auzerie J, Basilisco G, Camboni G, Manara L. Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A). Eur J Clin Pharmacol. 1988;35(5):529-34. PubMed PMID: 2906873.